Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |